PNC FINANCIAL SERVICES GROUP, INC. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$42,586
+29.8%
848
+63.4%
0.00%
Q2 2023$32,800
+46.4%
519
+4.2%
0.00%
Q1 2023$22,405
-24.0%
498
-26.0%
0.00%
Q4 2022$29,484
-89.7%
673
-84.5%
0.00%
Q3 2022$287,000
-9.7%
4,349
-30.9%
0.00%
Q2 2022$318,000
-17.8%
6,294
+3.8%
0.00%
Q1 2022$387,000
-40.2%
6,064
+0.4%
0.00%
-100.0%
Q4 2021$647,000
+2.2%
6,041
-2.0%
0.00%0.0%
Q3 2021$633,000
+18.5%
6,164
+1.6%
0.00%
Q2 2021$534,000
-19.7%
6,064
-11.5%
0.00%
-100.0%
Q1 2021$665,000
-6.7%
6,849
+7.7%
0.00%0.0%
Q4 2020$713,000
-4.9%
6,358
-21.4%
0.00%0.0%
Q3 2020$750,000
+32.5%
8,093
+11.5%
0.00%0.0%
Q2 2020$566,000
+31.6%
7,261
-1.5%
0.00%0.0%
Q1 2020$430,000
+3.9%
7,371
+42.8%
0.00%
Q4 2019$414,000
+3.0%
5,160
-5.8%
0.00%
Q3 2019$402,000
-14.1%
5,476
+10.0%
0.00%
Q2 2019$468,000
+61.4%
4,976
+37.6%
0.00%
Q1 2019$290,000
+26.6%
3,616
-15.0%
0.00%
Q4 2018$229,000
-19.6%
4,255
+16.2%
0.00%
Q3 2018$285,000
-72.4%
3,661
-77.5%
0.00%
-100.0%
Q2 2018$1,031,000
-16.5%
16,237
+20.5%
0.00%0.0%
Q1 2018$1,235,000
+18.1%
13,476
-2.7%
0.00%0.0%
Q4 2017$1,046,00013,8550.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders